Over two decades of operational leadership experience across diverse continents and industries, most recently as president and CEO of Eargo, a medical device developer of innovative hearing aids. Previously an executive at GN Group, a global leader in intelligent audio solutions. Early career in investment banking before transitioning to McKinsey & Company.

Lead developer of SAINT and previously Director of Innovation at Stanford Brain Stimulation Lab. Brandon is a Psychiatrist, technologist, and neuroscientist with record of NASA and NIH-funded research in basic and clinical domains.

Three decades of executive leadership and business development in global healthcare with an established track record of success in large pharma and multiple startup companies. Most recently, CFO and Head of Business Development at ImmPACT Bio USA, Inc., a cell therapy company focused on oncology and autoimmune diseases. Early career in M&A and corporate development at Bayer AG.

Two decades of leadership in neurosurgery, biotech and medical devices with a proven track record of driving innovation and growth. Most recently, CMO at Insightec, where he helped grow the company into a $1.5 B unicorn. Previously co-founded Insightec Biopharma and led development of AI-enabled neuro-diagnostic technologies at Openwater. Early academic career at Stanford, Loma Linda and John Wayne Cancer Inst.

Over 20 years of experience in medical quality assurance, regulatory and clinical affairs. Previously VP of Regulatory, Quality and Clinical Affairs at Nesos Corp., Senior Director of Regulatory Affairs and Clinical at Nevro Corp., and Director of Regulatory Affairs at Boston Neuromodulation.

20 years’ experience in advanced medical imaging software, previously VP of Software Engineering for Advanced Scanners. Technical leader at HeartFlow and Siemens, and holder of 15+ US and international patents.